JEANNINE EVERETT: Open Payments
NPI 1083614952 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 37 payments from 7 companies in 2025. Trend: 2023 $121 · 2024 $850 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 14 | $305 |
| Neurocrine BioSciences, Inc. | 9 | $181 |
| Teva Pharmaceuticals USA, Inc. | 10 | $150 |
| Lundbeck LLC | 1 | $29 |
| ABBVIE INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: HETLIOZ, INGREZZA, AUSTEDO XR, FANAPT, REXULTI, VRAYLAR, LYBALVI, COBENFY.
Industry payments across FL — which companies pay providers there.
